The Role of Patient-Derived Organoids in Triple-Negative Breast Cancer Drug Screening
Triple-negative breast cancer (TNBC) is one of the most aggressive breast cancer subtypes, with a grave prognosis and few effective treatment options. Organoids represent revolutionary three-dimensional cell culture models, derived from stem or differentiated cells and preserving the capacity to dif...
Main Authors: | Iason Psilopatis, Amalia Mantzari, Kleio Vrettou, Stamatios Theocharis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/3/773 |
Similar Items
-
Organoids: A New Chapter in Sarcoma Diagnosis and Treatment
by: Iason Psilopatis, et al.
Published: (2022-09-01) -
Patient-Derived Organoids: The Beginning of a New Era in Ovarian Cancer Disease Modeling and Drug Sensitivity Testing
by: Iason Psilopatis, et al.
Published: (2022-12-01) -
Unveiling Epigenetic Vulnerabilities in Triple-Negative Breast Cancer through 3D Organoid Drug Screening
by: Xinxin Rao, et al.
Published: (2024-02-01) -
The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer
by: Jordane Divoux, et al.
Published: (2023-09-01) -
The Role of Bitter Melon in Breast and Gynecological Cancer Prevention and Therapy
by: Iason Psilopatis, et al.
Published: (2023-05-01)